M.F. Mosele

485 total citations
4 papers, 54 citations indexed

About

M.F. Mosele is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M.F. Mosele has authored 4 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in M.F. Mosele's work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (1 paper) and Cancer Genomics and Diagnostics (1 paper). M.F. Mosele is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (1 paper) and Cancer Genomics and Diagnostics (1 paper). M.F. Mosele collaborates with scholars based in France, Japan and United States. M.F. Mosele's co-authors include Agnès Ducoulombier, Fabrice André, D. Tran, Christelle Lévy, Amélie Lusque, Élise Deluche, Véronique Dièras, Magali Lacroix‐Triki, Nathalie Droin and Barbara Pistilli and has published in prestigious journals such as Annals of Oncology and ESMO Open.

In The Last Decade

M.F. Mosele

3 papers receiving 54 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.F. Mosele France	3	51	37	17	8	8	4	54
Alicia Tran Dien France	3	40 0.8×	30 0.8×	13 0.8×	7 0.9×	7 0.9×	3	43
Frances Valdes-Albini United States	2	49 1.0×	28 0.8×	17 1.0×	11 1.4×	14 1.8×	3	62
Thomas Grinda France	5	55 1.1×	17 0.5×	25 1.5×	12 1.5×	14 1.8×	25	76
M.J. Piccart-Gebhart Italy	4	60 1.2×	29 0.8×	11 0.6×	8 1.0×	18 2.3×	6	65
Lyn Chan Australia	6	37 0.7×	59 1.6×	56 3.3×	9 1.1×	7 0.9×	6	93
Qilong Zhang China	4	41 0.8×	11 0.3×	29 1.7×	10 1.3×	14 1.8×	9	50
Alice C. Durham United Kingdom	3	35 0.7×	21 0.6×	10 0.6×	12 1.5×	9 1.1×	3	46
Shahid Ashfaque Japan	5	92 1.8×	22 0.6×	54 3.2×	8 1.0×	18 2.3×	7	107
M. Untch Germany	4	40 0.8×	14 0.4×	10 0.6×	9 1.1×	15 1.9×	14	52
Virginia Wolstenholme United Kingdom	4	31 0.6×	9 0.2×	34 2.0×	10 1.3×	6 0.8×	6	54

Countries citing papers authored by M.F. Mosele

Since Specialization

Citations

This map shows the geographic impact of M.F. Mosele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Mosele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Mosele more than expected).

Fields of papers citing papers by M.F. Mosele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Mosele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Mosele. The network helps show where M.F. Mosele may publish in the future.

Co-authorship network of co-authors of M.F. Mosele

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Mosele. A scholar is included among the top collaborators of M.F. Mosele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Mosele. M.F. Mosele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Mosele, M.F., et al.. (2025). 79P Molecular features of metastatic breast cancer (MBC) among young adults (YA). ESMO Open. 10. 104633–104633.

2.

D’Hondt, Véronique, Cécile Vicier, Jean‐Sébastien Frenel, et al.. (2023). 189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01). ESMO Open. 8(1). 101378–101378. 13 indexed citations

3.

Mosele, M.F., Amélie Lusque, Véronique Dièras, et al.. (2022). LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial. Annals of Oncology. 33. S123–S123. 37 indexed citations

4.

Mosele, M.F., Amélie Lusque, Alicia Tran Dien, et al.. (2019). Outcome and mutational landscape of patients with PIK3CA-mutated metastatic breast cancer (mBC). Annals of Oncology. 30. iii47–iii47. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact